injectable glp 1 agonist Five Unexpected New Uses for GLP-1 Receptor Agonists GLP-1 agonists approved for clinical

S.GadeT

These drugs are injectable and not recommended as primary treatment for DM

medRxiv 26(9):39063913 Wharton S et al (2019) The effectiveness and safety of pharmaceuticals to manage excess weight post-bariatric surgery: a systematic literature review

It has become a cross-disciplinary practice , shaped by clinical innovation, patient demand, and the rapid expansion of digital healthcare

Furthermore, some were these drugs were associated with potential undesirable effects, such as the risk of heart failure or fractures (complications that are especially prevalent in patients with CKD), this is the case of thiazolidinediones, and the use of sulfonylureas and insulin are associated with weight gain or the risk of hypoglycemia

The anorexigenic effect of GLP-1 seems to be transduced via GLP-1R signaling in several areas of the brain, including both hypothalamic nuclei and the hindbrain